Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06520085

Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
VieCuri Medical Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background: Mobile health (mHealth) - the use of medical applications in healthcare settings - include tools that can support self-management after surgery and thereby contribute to early postoperative recovery. Providing patients with timely and interactive information through mHealth is hypothesized to positively influence recovery after reverse shoulder arthroplasty (RSA). Aim: The aim of this study is to determine the effectiveness of interactive and personalized information and rehabilitation protocol with a mobile application compared to generic information and generic rehabilitation protocol (standard care) on postoperative recovery in patients undergoing primary RSA. Methods and analysis: A multicentre randomised controlled trial will be conducted in two Dutch hospitals. In total 170 patients undergoing elective, primary RSA will be included. Participants will be randomly allocated to one of the two groups on a 1:1 ratio. The intervention group will receive interactive postoperative information on a daily basis. The control group will receive standard care. The primary outcome is defined as functional recovery measured using the Oxford Shoulder Score (OSS) at 6 weeks. Secondary outcomes are: pain, physical functioning, quality of life, length of stay, complications, treatment satisfaction and app use. The between group difference will be analysed using linear mixed-effects regression.

Conditions

Interventions

TypeNameDescription
OTHERinteractive mHealth application for patients undergoing RSAPatients will receive interactive information via an mHealth application tailored to their needs and progress during the rehabilitation period after RSA.

Timeline

Start date
2024-08-01
Primary completion
2026-07-01
Completion
2026-12-31
First posted
2024-07-25
Last updated
2024-07-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06520085. Inclusion in this directory is not an endorsement.